Distinct but complementary contributions ...
Title :
Distinct but complementary contributions of PPAR isotypes to energy homeostasis
Author(s) :
Dubois, Vanessa [Auteur]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Eeckhoute, Jérôme [Auteur]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Lefebvre, Philippe [Auteur]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Staels, Bart [Auteur correspondant]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Eeckhoute, Jérôme [Auteur]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Lefebvre, Philippe [Auteur]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Staels, Bart [Auteur correspondant]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Journal title :
JOURNAL OF CLINICAL INVESTIGATION
Pages :
1202 - 1214
Publisher :
American Society for Clinical Investigation
Publication date :
2017-04-03
ISSN :
0021-9738
HAL domain(s) :
Sciences du Vivant [q-bio]/Médecine humaine et pathologie
English abstract : [en]
Peroxisome proliferator-activated receptors (PPARs) regulate energy metabolism and hence are therapeutic targets in metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease. While they share ...
Show more >Peroxisome proliferator-activated receptors (PPARs) regulate energy metabolism and hence are therapeutic targets in metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease. While they share anti-inflammatory activities, the PPAR isotypes distinguish themselves by differential actions on lipid and glucose homeostasis. In this Review we discuss the complementary and distinct metabolic effects of the PPAR isotypes together with the underlying cellular and molecular mechanisms, as well as the synthetic PPAR ligands that are used in the clinic or under development. We highlight the potential of new PPAR ligands with improved efficacy and safety profiles in the treatment of complex metabolic disorders.Show less >
Show more >Peroxisome proliferator-activated receptors (PPARs) regulate energy metabolism and hence are therapeutic targets in metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease. While they share anti-inflammatory activities, the PPAR isotypes distinguish themselves by differential actions on lipid and glucose homeostasis. In this Review we discuss the complementary and distinct metabolic effects of the PPAR isotypes together with the underlying cellular and molecular mechanisms, as well as the synthetic PPAR ligands that are used in the clinic or under development. We highlight the potential of new PPAR ligands with improved efficacy and safety profiles in the treatment of complex metabolic disorders.Show less >
Language :
Anglais
Popular science :
Non
ANR Project :
Source :
Files
- https://www.hal.inserm.fr/inserm-01709972/document
- Open access
- Access the document
- https://www.hal.inserm.fr/inserm-01709972/file/Figures_JCIreview_revision_final.pdf
- Open access
- Access the document
- https://www.hal.inserm.fr/inserm-01709972/document
- Open access
- Access the document
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373878/pdf
- Open access
- Access the document
- https://www.hal.inserm.fr/inserm-01709972/document
- Open access
- Access the document
- document
- Open access
- Access the document
- JCIreview_revision_final.pdf
- Open access
- Access the document
- Figures_JCIreview_revision_final.pdf
- Open access
- Access the document
- Open access
- Access the document
- document
- Open access
- Access the document
- JCIreview_revision_final.pdf
- Open access
- Access the document
- Figures_JCIreview_revision_final.pdf
- Open access
- Access the document